Chief Executive Officer
Roy Smythe, M.D. is the Chief Executive Officer at SomaLogic. He has had a diverse career as an internationally recognized surgeon, biomedical scientist, academician, health system administrator and healthcare business entrepreneur.
Dr. Smythe came to SomaLogic from Royal Philips, where he served as Global Chief Medical Officer for Strategy and Partnerships. Before joining Philips, he served as Chief Medical Officer at Valence Health, a Chicago-based healthcare company. He held the same title previously at AVIA, a healthcare technology accelerator.
Prior to his corporate healthcare roles, Dr. Smythe was the Medical Director of Innovation and Senior Vice President for Institute Development at Baylor Scott & White Health System, where he also chaired the Department of Surgery. Previously, he was the Roney Endowed Chair at the Texas A&M Health Science Center College of Medicine. His medical and translational research career began at the University of Texas MD Anderson Cancer Center.
Dr. Smythe received his bachelor’s degree in biology from Baylor University and his Doctor of Medicine from Texas A&M University. He was a Charles A. Dana Foundation Scholar at the University of Pennsylvania School of Medicine and the Wharton School of Business. He trained in general surgery, surgical oncology and thoracic surgery and completed a postdoctoral research fellowship in molecular therapeutics.